Evidence map›Paper›PMID 34748825›Full record

ArticleThe Journal of infection2022

Divergent humoral responses in mild to moderate SARS-CoV-2 infection over time - indication of persistence of the virus?

Justus J Bürgi, Matthias Rösslein, Henry Hornung, Jana Jentsch, Viveka L Boller, Günter Dollenmaier, Peter Wick, Karen Peier, Brigitte Nohynek, Aldo Fischer and 6 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Justus J BürgiCenter for Laboratory Medicine, Frohbergstrasse 3, 9000 St. Gallen, Switzerland.
Matthias RössleinEmpa - Swiss Federal Laboratories for Materials Science and Technology, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland; Cantonal Corona Study Group, Oberer Graben 32, 9001 St. Gallen, Switzerland.
Henry HornungCenter for Laboratory Medicine, Frohbergstrasse 3, 9000 St. Gallen, Switzerland.
Jana JentschCenter for Laboratory Medicine, Frohbergstrasse 3, 9000 St. Gallen, Switzerland.
Viveka L BollerCenter for Laboratory Medicine, Frohbergstrasse 3, 9000 St. Gallen, Switzerland.
Günter DollenmaierCenter for Laboratory Medicine, Frohbergstrasse 3, 9000 St. Gallen, Switzerland.
Peter WickEmpa - Swiss Federal Laboratories for Materials Science and Technology, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland; Cantonal Corona Study Group, Oberer Graben 32, 9001 St. Gallen, Switzerland.
Karen PeierCantonal Corona Study Group, Oberer Graben 32, 9001 St. Gallen, Switzerland; Public Health Department, Oberer Graben 32, 9001 St. Gallen, Switzerland.
Brigitte NohynekCantonal Corona Study Group, Oberer Graben 32, 9001 St. Gallen, Switzerland.
Aldo FischerCantonal Corona Study Group, Oberer Graben 32, 9001 St. Gallen, Switzerland.
Raphael StolzCantonal Corona Study Group, Oberer Graben 32, 9001 St. Gallen, Switzerland.
Michele CettuzziCantonal Corona Study Group, Oberer Graben 32, 9001 St. Gallen, Switzerland.
Michael ReutCenter for Laboratory Medicine, Frohbergstrasse 3, 9000 St. Gallen, Switzerland.
Regine Garcia BoyCenter for Laboratory Medicine, Frohbergstrasse 3, 9000 St. Gallen, Switzerland.
Oliver NolteCenter for Laboratory Medicine, Frohbergstrasse 3, 9000 St. Gallen, Switzerland; Cantonal Corona Study Group, Oberer Graben 32, 9001 St. Gallen, Switzerland.
Wolfgang KorteCenter for Laboratory Medicine, Frohbergstrasse 3, 9000 St. Gallen, Switzerland; Cantonal Corona Study Group, Oberer Graben 32, 9001 St. Gallen, Switzerland. Electronic address: wolfgang.korte@zlmsg.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Antibodies, NeutralizingAntibodies, ViralHumansImmunity, HumoralImmunoglobulin ASARS-CoV-2Antibodies, NeutralizingAntibodies, ViralImmunoglobulin AAntibodiesCOVID-19IgASARS-CoV-2Serology

Identifiers

PMID34748825
PMCPMC8570801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.